Maternal self-medication and provision of nevirapine to newborns by women in Rakai, Uganda

Journal of Acquired Immune Deficiency Syndromes

Volumn 39, Issue 1, 2005, Pages 121-124

  Kagaayi, Joseph ^a   Dreyfuss, Michele L ^b   Kigozi, Godfrey ^a   Chen, Michael Z ^b   Wabwire Mangen, Fred ^c   Serwadda, David ^c   Wawer, Maria J ^d   Sewankambo, Nelson K ^c   Nalugoda, Fred ^a   Kiwanuka, Noah ^a   Kiddugavu, Meddie ^a   Gray, Ronald H ^b  

^a UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c MAKERERE UNIVERSITY   (Uganda)

^d Joseph L Mailman Sch of Pub Hlth ^*  (United States)

Author keywords

HIV AIDS; Mother to child HIV transmission; Nevirapine; Uganda; Voluntary counseling and testing

Indexed keywords

MULTIVITAMIN; NEVIRAPINE;

ADULT; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; DRUG EFFICACY; DRUG ERUPTION; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; JAUNDICE; MAJOR CLINICAL STUDY; NAUSEA; NEWBORN; NEWBORN INFECTION; PATIENT COUNSELING; PERINATAL INFECTION; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; SELF MEDICATION; SELF REPORT; UGANDA; VERTICAL TRANSMISSION; VOMITING;

ANTI-HIV AGENTS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; NEVIRAPINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RURAL POPULATION; SELF ADMINISTRATION; UGANDA;

EID: 20944433789     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000148530.66587.7c     Document Type: Article

References (12)

1. Asiimwe-Okiror G, Opio AA, Musinguzi J, et al. Change in sexual behaviour and decline in HIV infection among young pregnant women in urban Uganda. AIDS. 1997;11:1757-1763.
2. UNAIDS, UNICEF, WHO. Epidemiological Fact Sheets on HIV/AIDS and Sexually Transmitted Infections: Uganda. Geneva: UNAIDS; 2002.
3. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial [see comments]. Lancet. 1999;354:795-802.
4. Uganda Bureau of Statistics and ORC Macro. Uganda demographic and health survey 2000-2001. Calverton, MD: Uganda Bureau of Statistics and ORC Macro; 2001.
5. Uganda Ministry of Health. Uganda health services sector report FY 2004-2005. January 10, 2003.
6. Wawer MJ, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet. 1999;353:525-535.
7. Gray RH, Wabwire-Mangen F, Kigozi G, et al. Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. Am J Obstet Gynecol. 2001;185:1209-1217.
8. Stringer JS, Sinkala M, Chapman V, et al. Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine. AIDS. 2003;17:1659-1665.
9. Ayouba A, Tene G, Cunin P, et al. Low rate of mother-to-child transmission of HIV-1 after nevirapine intervention in a pilot public health program in Yaounde, Cameroon. J Acquir Immune Defic Syndr. 2003;34:274-280.
10. Quaghebeur A, Mutunga L, Mwanyumba F, et al. Low efficacy of nevirapine (HIVNET 012) in preventing perinatal HIV-1 transmission in a real-life situation. AIDS. 2004;18:1854-1856.
11. Temmerman M, Quaghebeur A, Mwanyumba F, et al. Mother-to-child HIV transmission in resource poor settings: how to improve coverage? AIDS. 2003;17:1239-1242.
12. Stringer JS, Sinkala M, Stout JP, et al. Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings. J Acquir Immune Defic Syndr. 2003;32:506-513.